Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
COGNITION THERAPEUTICS INC (CGTX)
|
Add to portfolio |
|
|
|
| Price: |
$6.89
| | Metrics |
| OS: |
30.3
|
M
| |
|
|
| Market cap: |
$209
|
M
| |
|
|
|
Net cash:
|
$37.2
|
M
| |
$1.23
|
per share
|
|
EV:
|
$172
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($38.5)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 15.5 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 29.8 |
| Gross profit | 0.0 | 0.0 | 0.0 | -14.4 |
| Gross margin | | | | -93.0% |
| Research and development | 30.3 | 18.6 | 12.9 | |
| General and administrative | 13.2 | 10.0 | 4.5 | 3.5 |
| EBIT | -43.6 | -28.6 | -17.4 | -17.8 |
| EBIT margin | | | | -115.3% |
| Pre-tax income | -21.4 | -11.7 | -7.8 | -4.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -21.4 | -16.2 | -12.1 | -8.8 |
| Net margin | | | | -56.7% |
| |
| Diluted EPS | ($0.91) | ($3.13) | ($23.76) | ($18.66) |
| Shares outstanding (diluted) | 23.6 | 5.2 | 0.5 | 0.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|